We also showed that inhibition of Tyk1/Jak2 with tofacitinib in lupus-prone mice produced an increase in GILZ expression, suggesting this pathway has an inhibitory effect on GILZ transcription. The gene discussed is TSC22D3; the disease is systemic lupus erythematosus.